Myc Induces miRNA-Mediated Apoptosis in Response to HDAC Inhibition in Hematologic Malignancies.

Adams CM, Hiebert SW, Eischen CM
Cancer Res. 2016 76 (3): 736-48

PMID: 26676759 · PMCID: PMC4738141 · DOI:10.1158/0008-5472.CAN-15-1751

Alterations in the expression or function of histone deacetylases (HDAC) contribute to the development and progression of hematologic malignancies. Consequently, the development and implementation of HDAC inhibitors has proven to be therapeutically beneficial, particularly for hematologic malignancies. However, the molecular mechanisms by which HDAC inhibition (HDACi) induces tumor cell death remain unresolved. Here, we investigated the effects of HDACi in Myc-driven B-cell lymphoma and five other hematopoietic malignancies. We determined that Myc-mediated transcriptional repression of the miR-15 and let-7 families in malignant cells was relieved upon HDACi, and Myc was required for their upregulation. The miR-15 and let-7 families then targeted and downregulated the antiapoptotic genes Bcl-2 and Bcl-xL, respectively, to induce HDACi-mediated apoptosis. Notably, Myc also transcriptionally upregulated these miRNA in untransformed cells, indicating that this Myc-induced miRNA-mediated apoptotic pathway is suppressed in malignant cells, but becomes reactivated upon HDACi. Taken together, our results reveal a previously unknown mechanism by which Myc induces apoptosis independent of the p53 pathway and as a response to HDACi in malignant hematopoietic cells.

©2015 American Association for Cancer Research.

MeSH Terms (10)

Animals Apoptosis Cell Line, Tumor Hematologic Neoplasms Histone Deacetylase Inhibitors Humans Mice, Inbred C57BL MicroRNAs Proto-Oncogene Proteins c-myc Transfection

Connections (1)

This publication is referenced by other Labnodes entities: